Cowen & Co. Maintains Outperform on Oracle, Lowers Price Target to $96
Cowen & Co. analyst J. Derrick Wood maintains Oracle (NYSE:ORCL) with a Outperform and lowers the price target from $98 to $96.
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
Gainers
Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in pre-market trading.
Volatility In Markets Increases Sharply Ahead Of Inflation Data, Fed’s Rate Decision
US stocks closed sharply higher on Monday, ahead of the much-awaited inflation data and interest rate decision from the Federal Reserve.
Economists project the US central bank, and the European Central Bank and Bank of England to all increase interest rates by 50 basis points.
Core & Main, ABM Industries And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Oracle Says Expects Q3 Revenue Growth Of 21%-23% In Constant Currency
-Reuters Citing Conference Call
Oracle Says Expect Organic Growth For FY23 Cloud Revenue Will Be Over 30% In Constant Currency
-Reuters Citing Conference Call
Top 15 Trending Stocks On WallStreetBets As Of Monday, Dec. 12, 2022 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Oracle Q2 EPS $1.21 Beats $1.18 Estimate, Sales $12.30B Beat $12.04B Estimate
Oracle (NYSE:ORCL) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is unchanged from the same period last year. The company reported quarterly
Here’s Where Amgen’s Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022
Amgen Inc's (NASDAQ: AMGN) deal to acquire Horizon Therapeutics (NASDAQ: HZNP) requires a sizable loan that ranks among the biggest debt commitments for